ClinicalTrials.gg
Sign In

Rhabdoid Tumor clinical trials

The registry lists 115 studies for Rhabdoid Tumor across more than 10 countries. 23 are recruiting or about to start. 23 of them are mainly about Rhabdoid Tumor (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Rhabdoid Tumor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
47
Active, not recruiting
22
Recruiting
20
Terminated
14
Withdrawn
5
Not yet recruiting
3

Phase

Phase 1
60
Phase 2
38
Phase 3
3
Early Phase 1
3

Where

United States
103
Canada
19
Puerto Rico
15
Australia
15
Spain
4
Germany
3

Who runs them

National Cancer Institute (NCI) (21) · St. Jude Children's Research Hospital (10) · Pediatric Brain Tumor Consortium (9) · Children's Oncology Group (8) · Baylor College of Medicine (6) · Seattle Children's Hospital (6) · Emory University (4) · M.D. Anderson Cancer Center (3)

What is being tested here

Drugs under test in Rhabdoid Tumor studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Nivolumab204
Cyclophosphamide129
Temozolomide107
Gemcitabine102
G 207102
Oncolytic HSV-1 G207102
Selinexor102
Fludarabine102
Gallium maltolate101
GDC-0084101

Drug classes tested here Alkylating agents 2 open · Antimetabolites 2 open · Immune checkpoint inhibitors 2 open · Tyrosine kinase inhibitors (TKIs) 1 open · PARP inhibitors 1 open

Coming up

0phase 3 studies under way
9studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9

Who these studies take

Of the 20 Rhabdoid Tumor studies recruiting now, 2 (10%) set no upper age limit and 18 (90%) stop at 75 or younger. 20 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 20
AgeWomenMen
1019 (95%)19 (95%)
1819 (95%)19 (95%)
307 (35%)7 (35%)
403 (15%)3 (15%)
502 (10%)2 (10%)
652 (10%)2 (10%)
752 (10%)2 (10%)
852 (10%)2 (10%)

Across all 115 studies, recruiting or not: 87% stop at 75 or younger and 85% at 65; 97% take children; 0% are for women only and 0% for men only; 1% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Rhabdoid Tumor studies take

Of 31 phase 1 interventional studies under Rhabdoid Tumor, half reached primary completion within 65 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 165 mo49–92 · 31 studies——
Phase 263 mo52–89 · 23 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Results posted1

Studies

Recruiting first, then most recently updated. Showing 50 of 115. Browse all 115 → or search them.